Percutaneous uptake and kinetics of methyl isobutyl ketone (MIBK) in the guinea-pig
Related Experiment Videos
E W Hjelm1, A Boman, P Fernström
1Division of Work and Environmental Physiology, National Institute of Occupational Health, Solna, Sweden.
Abstract:
Continuous intravenous infusion of 0.478 mumol/min methyl isobutyl ketone (MIBK) was performed for 30 min in pentobarbital-anesthetized guinea-pigs. Epicutaneous exposure for 150 min was carried out 2.5 h later after administration of MIBK to a sealed glass ring on the clipped back of the animals. Arterial blood was analyzed for MIBK by gas chromatography. Blood clearance averaged 201 ml.min-1.kg-1 body wt. A maximum percutaneous uptake of 1.1 mumol.min-1.cm-2 was reached 10-45 min after the onset of exposure and decreased to 0.56 mumol.min-1.cm-2 during the latter part of exposure.
Insights
Methyl isobutyl ketone (MIBK) was infused intravenously and applied topically to guinea pigs. Researchers measured MIBK blood clearance and percutaneous uptake rates to understand its absorption and elimination.
Area of Science:
- Toxicology
- Pharmacokinetics
- Dermal Absorption Studies
Background:
- Methyl isobutyl ketone (MIBK) is an industrial solvent with potential for human exposure.
- Understanding the absorption and elimination kinetics of MIBK is crucial for risk assessment.
Purpose of the Study:
- To investigate the pharmacokinetic profile of methyl isobutyl ketone (MIBK) following intravenous and epicutaneous administration in guinea pigs.
- To quantify MIBK blood clearance and percutaneous uptake rates.
Main Methods:
- Continuous intravenous infusion of MIBK in anesthetized guinea pigs.
- Epicutaneous exposure of MIBK on clipped animal skin within a sealed glass ring.
- Arterial blood sampling and analysis of MIBK concentrations using gas chromatography.
Main Results:
- Average blood clearance of MIBK was determined to be 201 ml/min/kg body weight.
- Maximum percutaneous uptake of MIBK reached 1.1 mumol/min/cm², observed between 10-45 minutes.
- Uptake rate decreased to 0.56 mumol/min/cm² later in the exposure period.
Conclusions:
- The study provides quantitative data on MIBK pharmacokinetics in a mammalian model.
- Results highlight significant percutaneous absorption of MIBK, with uptake rates varying over time.
- Findings contribute to understanding MIBK exposure risks and informing safety guidelines.